BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy

Xiaolong Tang(Anhui University of Science and Technology)
BioMed Research International
January 1, 2021
10.1155/2021/5556306
Cited by 25

Related Papers

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
|Journal of Cancer Research and Clinical Oncology|2020|19
ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinoma.
|PubMed|2023|4
Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
|Translational Cancer Research|2020|1